Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease
type: MedicalStudy
description: Extension to a Multicenter, Open-label Study to Assess the Safety and Efficacy of 600 μg SOM230, Administered Subcutaneously, Bid in Patients With Cushing's Disease
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2004-08-13
end date: 2013-07-08
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00171951
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Novartis Pharmaceuticals
study subject: Cushing Disease
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Cushing Disease

AI Analytics
type: Organization